News
Female-led biotech start-up raises £1.27m to develop drug delivery technology for cancer therapy
The London-based company aims to help combat late-stage cancers using proprietary technology

The preclinical biotech start-up Vitarka Therapeutics has secured £1.27m to “revolutionise” intracellular drug delivery through tumour-targeted technology.
Founded in 2021 by Dr Vineeta Tripathi, the company is developing combination medicines using RNAi therapies and a non-viral drug delivery platform to help combat late-stage cancers.
Its “tumour-targeted” platform technology, called EndoPore, aims to target solid tumours and deliver therapeutics for intracellular targets.
The new funds will be used to accelerate the the company’s technology for pre-clinical validation. The development plan will also progress towards pharmacokinetics studies and improving technical processes for large-scale manufacturing.
“It has just been a year since we defined our product so to raise such a substantial amount within this timeframe is remarkable,” said Tripathi.
“Our new investors bring a range of complementary expertise to Vitarka and we are delighted to be working with them. We thank them, together with Innovate UK, for all their support.”
Stephen Chambers, partner and managing director of IndiBio New York, part of SOSV, said: “At IndieBio, we look for companies that want to make a difference in the world and have the passion and skills to deliver on their dreams, and we found that in abundance with Vitarka.
“We are excited about this investment as it represents a unique opportunity to contribute to the advancement of medical treatments and improve patient outcomes.”
He added: “The RNAi and non-viral drug delivery space is full of untapped potential, and we are confident that Vitarka’s unique approach will unleash the full power of this emerging class of therapeutics.
“We are thrilled to continue supporting Vitarka and look forward to being a part of their growth and success.”
Hassan Mahmudul, investor, UKI2S and Future Planet Capital added: “Delivering RNA therapeutics into the right tissues without off-target toxicity is a major problem faced by the pharma industry.
“That is why we are excited to back Vitarka and their unique approach to drug delivery.
“Their development of a novel platform technology has the potential to provide a solution which safely combats tumours and we look forward to continuing our partnership with them”.
Menopause
AI maps how reproductive organs age differently during menopause
Cancer
Ovarian cancer cases rising among younger adults, study finds

Ovarian cancer cases are rising among younger adults in England, with bowel cancer showing a similar pattern, a new study suggests.
Researchers said excess weight is a key contributor, but is unlikely on its own to explain the pattern.
The authors wrote: “These patterns suggest that while similar risk factors across ages are likely, some cancers may have age-specific exposures, susceptibilities, or differences in screening and detection practices.”
They added: “Although overweight and obesity are linked to 10 of the 11 cancers evaluated and account for a substantial proportion of cancer cases, both BMI-attributable and BMI-non-attributable incidence rates have increased, though the latter more slowly, suggesting other contributors.”
The study analysed cancer incidence, meaning new diagnoses, in England between 2001 and 2019 across more than 20 cancer types, comparing adults aged 20 to 49 with those aged 50 and over.
Among younger women, cases of 16 out of 22 cancers increased significantly over the period, while among younger men, 11 out of 21 cancers increased significantly.
In particular, there was a significant rise in 11 cancers with known behavioural risk factors among adults under 50. These were thyroid, multiple myeloma, liver, kidney, gallbladder, bowel, pancreatic, endometrial, mouth, breast and ovarian cancers.
Rates of all 11 also rose significantly among adults aged 50 and over, with the notable exceptions of bowel and ovarian cancer.
Five cancers, endometrial, kidney, pancreatic, multiple myeloma and thyroid cancer, increased significantly faster in younger than in older women, while multiple myeloma increased faster in younger than in older men.
The researchers looked at established risk factors including smoking, alcohol intake, diet, physical inactivity and body mass index, a measure used to assess whether someone is underweight, a healthy weight, overweight or obese.
With the exception of mouth cancer, all 11 cancers were associated with obesity. Six, liver, bowel, mouth, pancreatic, kidney and ovarian, were also linked to smoking.
Four, liver, bowel, mouth and breast, were associated with alcohol intake. Three, bowel, breast and endometrial, were linked to physical inactivity, and one, bowel, was associated with dietary factors.
But apart from excess weight, trends in those risk factors over the past one to two decades were stable or improving among younger adults.
That suggests other factors may also play a part, including reproductive history, early-life or prenatal exposures, and changes in diagnosis and detection.
The study noted that red meat consumption fell among younger adults, while fibre intake remained stable or slightly improved in both sexes between 2009 and 2019, although more than 90 per cent of younger adults were still not eating enough fibre in 2018.
Established behavioural risk factors accounted for a substantial share of cancer cases.
Excess weight was the risk factor associated with most cancers in 2019, ranging from 5 per cent for ovarian cancer to 37 per cent for endometrial cancer.
The researchers said the findings were based on observational data, meaning the study could identify patterns but could not prove cause and effect.
They also noted there were no consistent long-term national data for several risk factors, that the analysis was limited to England rather than the UK, and that cancer remains far more common overall in older adults despite the rise in cases among younger people.
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Fertility7 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News4 weeks agoCopper coil vs Mirena: Which is right for you?















